Using comprehensive in silico analyses we prioritized CHEK1, CDC25A, and CCNE1 as candidate genes affecting the proliferation of ER+ BC, with two microRNAs from the miR‐497∼195 cluster identified as their potential regulators. The gene discussed is CHEK1; the disease is breast cancer.